Yaşar Çalışkan - Concepedia

Author

Yaşar Çalışkan

Also Known As

Caliskan, Y., I Serriello, Robyn Roth, Y Caliskan, Y. Caliskan, Y. Çalişkan, Y. Çalışkan, Y.K. Caliskan, Y.K. Calıskan, YAŞAR KEREM ÇALIŞKAN

317

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Istanbul University Saint Louis University University of Iowa University of Calgary Washington University in St. Louis

YÇ

About

Yaşar Çalışkan is an author at Istanbul University specializing in medicine, nephrology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	723
2	Public Health	3	3	93
3	Health Sciences	2	2	33
4	Endocrinology	2	2	57
5	Diabetes	1	1	16

Yaşar Çalışkan

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy Krzysztof Kiryluk, Elena Sánchez, Francesca Zanoni, Nature Genetics Genome-wide Association StudyGlomerulonephritisGenome-wide AssociationAutoimmune DiseaseMedicine	2023	156
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update Rosanna Coppo, Graziella D’Arrigo, Giovanni Tripepi, Nephrology Dialysis Transplantation	2018	105
Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy Rupali S. Avasare, Pietro A. Canetta, Andrew S. Bomback, Clinical Journal of the American Society of Nephrology	2018	98
Genomic Mismatch at <i>LIMS1</i> Locus and Kidney Allograft Rejection Nicholas J. Steers, Yifu Li, Zahida Drače, New England Journal of Medicine	2019	93
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort Rosanna Coppo, Danilo Lofaro, Roberta Camilla, Pediatric Nephrology Glomerular DiseaseGlomerulonephritisRenal DiseaseMedicineKidney Failure	2016	91
Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever Nilüfer Alpay, Abdullah Şumnu, Yaşar Çalışkan, Rheumatology International Healthcare-associated InfectionClinical InfectionInfection ControlAnakinra TreatmentClinical Infectious Disease	2010	76
Osteoprotegerin/RANKL Axis and Progression of Coronary Artery Calcification in Hemodialysis Patients Abdullah Özkök, Yaşar Çalışkan, S. K. Tamer, Clinical Journal of the American Society of Nephrology	2012	71
Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease Berna Yelken, Yaşar Çalışkan, Numan Görgülü, Clinical Nephrology	2011	68
Extrapulmonary tuberculosis in immunocompetent adults Arif Atahan Çağatay, Yaşar Çalışkan, Selçuk Aksöz, Scandinavian Journal of Infectious Diseases Pulmonary TuberculosisExtrapulmonary TuberculosisPulmonary PathologyClinical EpidemiologyPathology	2004	65
Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience Abdullah Özkök, Timur Selçuk Akpınar, Fatih Tufan, Clinical and Experimental Nephrology GlomerulonephritisUrologyRenal DiseaseRenal FunctionMedicine	2012	65

Page 1